表紙
市場調查報告書
商品編碼
1074289

病人參與解決方案的全球市場:各組件(軟體,服務),部署,治療領域(CVD,糖尿病,肥胖,健身),功能(電子處方箋,虛擬照護),終端用戶 - 至2027年的預測

Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User - Global Forecast to 2027

出版日期: | 出版商: MarketsandMarkets | 英文 205 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球病人參與解決方案的市場規模,在預測期間內預計以10.0%的年複合成長率發展,從2022年的173億美元,到2027年達到279億美元。

該市場的成長要素,是推動患者中心理關懷,在照護之旅全體中為了吸引患者的政府法規的引進和變更,病人參與解決方案的高需求,M-健康應用程式的利用擴大等。

可是,病人參與解決方案的互通性問題,及在醫療產業熟練的IT專家不足,抑制在預測期間內該市場的成長。

本報告提供全球病人參與解決方案市場的相關調查,市場動態,法規和價格的分析,生態系統,各市場區隔、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 市場動態
    • 促進因素
    • 限制
    • 市場機會
    • 課題
  • COVID-19對市場的影響
  • 案例研究
  • 生態系統分析
  • 科技分析
  • 法規分析
  • 價格分析
  • 波特的五力分析
  • 趨勢

第6章 各零件:病人參與解決方案市場

  • 硬體設備
  • 軟體
    • 獨立的軟體
    • 整合軟體軟體
  • 服務

第7章 各部署模式:病人參與解決方案市場

  • 內部部署方式
  • 雲端基礎的方式

第8章 各用途:病人參與解決方案市場

  • 健康管理
  • 家庭的健康管理
  • 社會性及行動性管理
  • 財政性健康管理

第9章 各治療領域:病人參與解決方案市場

  • 慢性疾病
    • 心血管疾病(CVD)
    • 糖尿病
    • 肥胖
    • 其他慢性疾病
  • 女性的健康
  • 健身
  • 其他

第10章 各功能:病人參與解決方案市場

  • 電子處方箋
  • 虛擬協商
  • 患者/客戶的調度
  • 文件管理

第11章 各終端用戶:病人參與解決方案市場

  • 供應商
  • 付款人
  • 患者
  • 其他

第12章 各地區:病人參與解決方案市場

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他
  • 其他地區
    • 南美
    • 中東、非洲

第13章 競爭情形

  • 概要
  • 主要企業的策略/成功機會
  • 主要市場參與企業的收益佔有率分析
  • 市場排行榜
  • 競爭基準
  • 競爭領導製圖
  • 競爭領導製圖 - Start-Ups/中小企業
  • 競爭形勢、趨勢

第14章 企業簡介

  • 其他企業
    • IBM
    • MCKESSON CORPORATION
    • ALLSCRIPTS HEALTHCARE SOLUTIONS INC
    • ATHENAHEALTH
    • ORION HEALTH
    • CERNER CORPORATION
    • GETWELLNETWORK, INC.
    • LINCOR SOLUTIONS
    • COGNIZANT
    • HARRIS HEALTHCARE
  • 其他企業
    • GET REAL HEALTH
    • ONEVIEW HEALTHCARE
    • ADVANCEDMD
    • EPIC SYSTEMS CORPORATION
    • MEDITECH
    • KAREO
    • ECLINICAL WORKS
    • WELLSTACK
    • IQVIA
    • VIVIFY HEALTH
    • MEDHOST
    • VALIDIC
    • CUREMD HEALTHCARE
    • MEDISYSINC.COM
    • PATIENTPOINT, LLC

第15章 附錄

目錄
Product Code: HIT 2767

The patient engagement solutions market is projected to reach USD 27.9 billion by 2027 from USD 17.3 billion in 2022, at a CAGR of 10.0% during the forecast period. The growth of this market is driven by the adoption and changes in government regulations to promote patient-centric care and involve patients throughout the care journey, high demand for patient engagement solutions, and the growing utilization of m- health apps.

However, interoperability issues for patient engagement solutions and a dreadth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period.

"Services segment is expected to grow at the highest rate during the forecast period"

On basis of components, the patient engagement solutions market is segmented into software, hardware, and services. The software segment accounted for the largest share of the global patient engagement solutions market in 2021. The software market is further segmented into standalone solutions and integrated solutions. In 2021, the integrated solutions segment has accounted for the larger share of this market & is also expected to grow at the highest CAGR during the forecast period.

However, the services segment is expected to grow at the highest CAGR during the forecast period. The high growth of the services segment can be attributed to the services being indispensable for the application of deployed solutions.

"The On-premise solutions segment is estimated to account for the largest share of the Patient Engagement Solutions market in 2022"

Based on delivery mode, the patient engagement solutions market is segmented into on-premise and cloud-based solutions. In 2021, the on-premise solutions segment accounted for the largest share of the global patient engagement solutions market. However, the cloud-based solutions segment is expected to register the highest CAGR during the forecast period. The flexibility, scalability, and affordability are the features offered by cloud-based solutions that are supporting its growth in the patient engagement solutions market.

"Health management segment in the applications accounted for the largest share of the global patient engagement solutions market"

Based on application, the patient engagement solutions market is segmented into health management, home health management, social and behavioral management, and financial health management. The health management applications segment accounted for the largest share of the global patient engagement solutions market in 2021. The large share of this segment can be attributed to the increased awareness among patients about the health conditions cause by severe diseases and their willingness to actively participate in maintaining their own health.

"Chronic diseases among the therapeutic areas accounted for the largest share of the global patient engagement solutions market"

Based on the therapeutic area, the patient engagement solutions market is segmented into chronic diseases, women's health, fitness, and other therapeutic areas. The chronic diseases segment accounted for the largest share of the global patient engagement solutions market in 2021. The large share of this segment can be attributed to the increase in various chronic diseases and the need to manage these conditions with reduced healthcare costs.

"The E- Prescribing functionality is expected to grow with the highest CAGR during the forecast period"

Based on functionality, the patient engagement solutions market is segmented into E-prescribing, virtual consultation, patient/client scheduling, and document management. The patient/client scheduling segment accounted for the largest share of the global patient engagement solutions market in 2021. The large share of this segment can be attributed to the increasing productivity and efficient care through proper scheduling of appointments. The E- Prescribing segment is expected to grow with the highest CAGR during the forecast period

"Providers' segment accounted for the largest share of the global patient engagement solutions market"

Based on end users, the patient engagement solutions market is segmented into providers, payers, patients, and other end users. The providers' segment accounted for the largest share of the global patient engagement solutions market in 2021. High adoption of patient engagement solutions to curtail rising healthcare costs, offer value-based care, and improve financial outcomes are factors that are supporting the growth of this segment. Patient engagement solutions also help providers to improve patient experience, meet the increasing demand for convenient access to health information, and better serve patients to self-manage their care.

"North America to dominate the patient engagement solutions market in 2022"

North America accounted for the largest share of the global patient engagement solutions market in 2021. Changing government initiatives and regulations in the region , the need to cut down on healthcare costs, the rising prevalence of chronic diseases, and the key market players operating in the region are the key factors driving the growth of the patient engagement solutions market in North America.

The Asia Pacific market is projected to register the highest CAGR during the forecast period, owing to the increasing adoption of HCIT solutions and the growing prevalence of chronic diseases in the region.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (41%), Tier 2 (31%), and Tier 3 (28%)
  • By Designation: C-level (44%), Director-level (35%), and Others (21%)
  • By Region: North America (46%), Europe (26%), Asia Pacific (18%), and RoW (10%)

Prominent players in this market are: IBM (US), McKesson Corporation (US), Allscripts (US), Cerner Corporation (US), Epic Systems Corporation (US), Orion Health (New Zealand), GetWellNetwork (US), athenahealth (US), Oneview Healthcare (Ireland), MEDITECH (US), IQVIA (US), Get Real Health (US), Cognizant (US), Symphony Care (US), Harris Healthcare (US), Kareo (US), CureMD Healthcare (US), eClinicalWorks (US), and Lincor Solutions (US), AdvancedMD (US), WellStack(US), IQVIA (US), Vivify Health (US), Medhost (US), Validic (US) MEDISYSINC (US), and Patient point LLC (US). These players are increasingly focusing on new product launches and partnerships to expand their product offerings in the patient engagement solutions market.

Research Coverage:

  • The report studies the Patient Engagement Solutions market based on component, delivery mode, therapeutic area, application, functionality, end user, and region
  • The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
  • The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
  • The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total remote patient monitoring market
  • The report forecasts the revenue of market segments with respect to five major regions

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the Patient Engagement Solutions market and provides them information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 PATIENT ENGAGEMENT SOLUTIONS MARKET: INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
    • 1.5.1 SCOPE-RELATED LIMITATIONS
    • 1.5.2 METHODOLOGY-RELATED LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY RESEARCH
  • 2.2 PRIMARY SOURCES
    • 2.2.1 KEY INDUSTRY INSIGHTS
    • 2.2.2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION METHODOLOGY
    • FIGURE 2 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • 2.4 MARKET ESTIMATION
    • 2.4.1 RESEARCH METHODOLOGY: MARKET ESTIMATION
    • 2.4.2 APPROACH: END USER-BASED MARKET ESTIMATION
    • FIGURE 3 RESEARCH METHODOLOGY: MARKET ESTIMATION
    • 2.4.3 TOP-DOWN APPROACH: CONTRIBUTION-BASED MARKET SIZE ESTIMATION
    • 2.4.4 PATIENT ENGAGEMENT SOLUTIONS MARKET: TOP-DOWN APPROACH
    • 2.4.5 GROWTH FORECAST
    • FIGURE 4 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE LABORATORY INFORMATICS MARKET (2022-2027)
    • FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • 2.5 MARKET DATA ESTIMATION AND TRIANGULATION
    • FIGURE 6 DATA TRIANGULATION METHODOLOGY
  • 2.6 ASSUMPTIONS FOR THE STUDY
  • 2.7 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT: PATIENT ENGAGEMENT SOLUTIONS MARKET
  • 2.8 LIMITATIONS

3 EXECUTIVE SUMMARY

    • FIGURE 7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION)
    • FIGURE 8 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    • FIGURE 10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2022 VS. 2027 (USD MILLION)
    • FIGURE 11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022 VS. 2027 (USD MILLION)
    • FIGURE 12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    • FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE PATIENT ENGAGEMENT SOLUTIONS MARKET

4 PREMIUM INSIGHTS

  • 4.1 PATIENT ENGAGEMENT SOLUTIONS MARKET OVERVIEW
    • FIGURE 14 RISING GOVERNMENT INITIATIVES FOR PATIENT-CENTRIC CARE DRIVE THE MARKET GROWTH
  • 4.2 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER
    • FIGURE 15 PROVIDERS ACCOUNTED FOR THE LARGEST SHARE OF THE PATIENT ENGAGEMENT SOLUTIONS MARKET IN 2021
  • 4.3 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE & COUNTRY (2021)
    • FIGURE 16 ON-PREMISE SOLUTIONS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2021
  • 4.4 GEOGRAPHICAL SNAPSHOT OF THE PATIENT ENGAGEMENT SOLUTIONS MARKET
    • FIGURE 17 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 18 PATIENT ENGAGEMENT SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Implementation of government regulations and initiatives to promote patient-centric care
      • 5.2.1.2 Increasing adoption of patient engagement solutions
      • 5.2.1.3 Rising number of collaborations and partnerships between stakeholders
    • TABLE 2 INDICATIVE LIST OF COLLABORATIONS BETWEEN ORGANIZATIONS FROM 2020 TO 2022
      • 5.2.1.4 Increasing utilization of mobile health apps
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Large investment requirements for healthcare infrastructure
      • 5.2.2.2 Protection of patient information
      • 5.2.2.3 Inadequate interoperability across healthcare providers
      • 5.2.2.4 Shortage of skilled IT professionals in the healthcare industry
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth opportunities in emerging markets
      • 5.2.3.2 Wearable health technology
      • 5.2.3.3 Cloud-computing solutions
    • 5.2.4 CHALLENGES
      • 5.2.4.1 High deployments costs of healthcare IT systems
      • 5.2.4.2 Low levels of healthcare literacy
  • 5.3 IMPACT OF COVID-19 ON THE PATIENT ENGAGEMENT SOLUTIONS MARKET
  • 5.4 CASE STUDIES
    • 5.4.1 FOCUS ON REDUCING READMISSION RATES AND IMPROVING CARE
      • 5.4.1.1 Case 1: Need to reduce patient hospital stays
    • 5.4.2 IMPROVE OUTPATIENT COMMUNICATION
      • 5.4.2.1 Case 2: Rising need to curb miscommunication with discharged patients
    • 5.4.3 PATIENT ENGAGEMENT STRATEGY
      • 5.4.3.1 Case 3: Post-discharge care
  • 5.5 ECOSYSTEM ANALYSIS
    • FIGURE 19 PATIENT ENGAGEMENT SOLUTIONS MARKET: ECOSYSTEM ANALYSIS
  • 5.6 TECHNOLOGY ANALYSIS
    • TABLE 3 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS
  • 5.7 REGULATORY ANALYSIS
    • 5.7.1 HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT OF 1996 (HIPAA)
    • 5.7.2 HEALTH INFORMATION TECHNOLOGY FOR ECONOMIC AND CLINICAL HEALTH ACT OF 2009 (HITECH)
    • 5.7.3 CONSUMER PRIVACY PROTECTION ACT OF 2017
    • 5.7.4 NATIONAL CYBERSECURITY PROTECTION ADVANCEMENT ACT OF 2015
    • 5.7.5 CYBERSECURITY LAW OF THE PEOPLE'S REPUBLIC OF CHINA
    • 5.7.6 AFFORDABLE CARE ACT, 2010
  • 5.8 PRICING ANALYSIS
  • 5.9 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 4 PATIENT ENGAGEMENT SOLUTION MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 5.10 INDUSTRY TRENDS
    • 5.10.1 RISING NEED FOR INTEROPERABILITY & INTEGRATION OF HCIT SOLUTIONS
    • 5.10.2 GRADUAL SHIFT OF ACCOUNTABILITY FROM PAYERS TO PROVIDERS
    • 5.10.3 GROWING DEMAND FOR VALUE-BASED HEALTHCARE

6 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT

  • 6.1 INTRODUCTION
    • TABLE 5 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
  • 6.2 HARDWARE
    • 6.2.1 HARDWARE SOLUTIONS ARE AN INTERACTIVE EXPERIENCE FOR PATIENTS & FAMILIES
    • TABLE 6 HARDWARE MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 6.3 SOFTWARE
    • TABLE 7 SOFTWARE MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 8 SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 6.3.1 STANDALONE SOFTWARE
      • 6.3.1.1 Standalone software refers to the traditional software installed in client systems
    • TABLE 9 STANDALONE SOFTWARE MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.3.2 INTEGRATED SOFTWARE
      • 6.3.2.1 Reduction in time spent on data management is driving the growth of this segment
    • TABLE 10 INTEGRATED SOFTWARE MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 6.4 SERVICES
    • 6.4.1 THE SERVICES SEGMENT IS EXPECTED TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
    • TABLE 11 SERVICES MARKET, BY REGION, 2020-2027(USD MILLION)

7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE

  • 7.1 INTRODUCTION
    • TABLE 12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020-2027(USD MILLION)
  • 7.2 ON-PREMISE MODE
    • 7.2.1 PATIENT DATA SAFETY AND COST BENEFITS OF ON-PREMISE DELIVERY MODES TO DRIVE THE MARKET GROWTH
    • TABLE 13 ON-PREMISE MODE MARKET, BY REGION, 2020-2027(USD MILLION)
  • 7.3 CLOUD-BASED MODE
    • 7.3.1 REGULATORY REQUIREMENTS HAVE DRIVEN HEALTHCARE PROVIDERS TO ADOPT CLOUD-BASED SOLUTIONS
    • TABLE 14 CLOUD-BASED MODE MARKET, BY REGION, 2020-2027(USD MILLION)

8 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 15 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020-2027(USD MILLION)
  • 8.2 HEALTH MANAGEMENT
    • 8.2.1 HEALTH MANAGEMENT PLAYS A CRUCIAL TOOL IN GUIDING PATIENTS IN SELF-CARE
    • TABLE 16 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT, BY REGION, 2020-2027(USD MILLION)
  • 8.3 HOME HEALTH MANAGEMENT
    • 8.3.1 GROWING PREFERENCE FOR HOME HEALTHCARE TO SUPPORT THE MARKET GROWTH
    • TABLE 17 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT, BY REGION, 2020-2027(USD MILLION)
  • 8.4 SOCIAL & BEHAVIORAL MANAGEMENT
    • 8.4.1 GROWING POPULARITY OF SOCIAL MEDIA TO DRIVE THE MARKET GROWTH
    • TABLE 18 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY REGION, 2020-2027(USD MILLION)
  • 8.5 FINANCIAL HEALTH MANAGEMENT
    • 8.5.1 FINANCIAL ENGAGEMENT SOLUTIONS HELP PROVIDERS MANAGE PATIENT PAYMENTS
    • TABLE 19 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY REGION, 2020-2027(USD MILLION)

9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA

  • 9.1 INTRODUCTION
    • TABLE 20 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
  • 9.2 CHRONIC DISEASES
    • TABLE 21 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 22 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2020-2027 (USD MILLION)
    • 9.2.1 CARDIOVASCULAR DISEASES (CVD)
      • 9.2.1.1 CVD is the leading cause of death worldwide
    • TABLE 23 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CVD, BY REGION, 2020-2027 (USD MILLION)
    • 9.2.2 DIABETES
      • 9.2.2.1 The high incidence of diabetes worldwide drives the growth of this segment
    • TABLE 24 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY REGION, 2020-2027 (USD MILLION)
    • 9.2.3 OBESITY
      • 9.2.3.1 Rising prevalence of obesity to drive the growth of this segment
    • TABLE 25 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY REGION, 2020-2027 (USD MILLION)
    • 9.2.4 OTHER CHRONIC DISEASES
    • TABLE 26 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY REGION, 2020-2027 (USD MILLION)
  • 9.3 WOMEN'S HEALTH
    • 9.3.1 INCREASING SELF AWARENESS FOR THE MANAGEMENT OF DISEASES TO DRIVE THE MARKET GROWTH
    • TABLE 27 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN'S HEALTH, BY REGION, 2020-2027 (USD MILLION)
  • 9.4 FITNESS
    • 9.4.1 GROWING PREFERENCE FOR A HEALTHY LIFESTYLE TO SUPPORT THE MARKET GROWTH FOR FITNESS-RELATED APPS
    • TABLE 28 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY REGION, 2020-2027 (USD MILLION)
  • 9.5 OTHER THERAPEUTIC AREAS
    • TABLE 29 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2020-2027 (USD MILLION)

10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY

  • 10.1 INTRODUCTION
    • TABLE 30 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2020-2027 (USD MILLION)
    • 10.1.1 E-PRESCRIBING
      • 10.1.1.1 E-prescribing is a cost-effective method of providing valuable information to clinicians to enhance decision-making
    • TABLE 31 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY REGION, 2020-2027 (USD MILLION)
    • 10.1.2 VIRTUAL CONSULTATION
      • 10.1.2.1 Telehealth provides flexibility in treatment options due to remote monitoring
    • TABLE 32 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR VIRTUAL CONSULTATION, BY REGION, 2020-2027 (USD MILLION)
    • 10.1.3 PATIENT/CLIENT SCHEDULING
      • 10.1.3.1 Patient/client scheduling enables physicians to streamline workflows and efficiently manage patient schedules
    • TABLE 33 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY REGION, 2020-2027 (USD MILLION)
    • 10.1.4 DOCUMENT MANAGEMENT
      • 10.1.4.1 The effective management of patient documents is crucial for healthcare providers
    • TABLE 34 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY REGION, 2020-2027 (USD MILLION)

11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER

  • 11.1 INTRODUCTION
    • TABLE 35 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 11.2 PROVIDERS
    • 11.2.1 PROVIDERS ARE THE LARGEST END USERS OF PATIENT ENGAGEMENT SOLUTIONS
    • TABLE 36 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY REGION, 2020-2027 (USD MILLION)
  • 11.3 PAYERS
    • 11.3.1 PATIENT ENGAGEMENT SOLUTIONS HELP HEALTHCARE PAYERS MINIMIZE ERRORS
    • TABLE 37 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY REGION, 2020-2027 (USD MILLION)
  • 11.4 PATIENTS
    • 11.4.1 PATIENT ENGAGEMENT SOLUTIONS MOTIVATE INDIVIDUALS TO MONITOR & IMPROVE HEALTH OUTCOMES
    • TABLE 38 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY REGION, 2020-2027 (USD MILLION)
  • 11.5 OTHER END USERS
    • TABLE 39 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY REGION, 2020-2027 (USD MILLION)

12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION

  • 12.1 INTRODUCTION
    • TABLE 40 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2020-2027(USD MILLION)
  • 12.2 NORTH AMERICA
    • FIGURE 20 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
    • TABLE 41 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 42 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 43 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 44 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 45 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 46 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 47 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2020-2027 (USD MILLION)
    • 12.2.1 US
      • 12.2.1.1 The US is the largest market in North America for patient engagement solutions in 2022
    • TABLE 48 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 49 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 50 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 51 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 52 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • 12.2.2 CANADA
      • 12.2.2.1 Growing need for cost containment to propel the market growth in Canada
    • TABLE 53 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 54 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 55 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 56 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 57 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
  • 12.3 EUROPE
    • TABLE 58 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 59 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 60 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 61 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 62 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 63 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 64 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2020-2027(USD MILLION)
    • 12.3.1 GERMANY
      • 12.3.1.1 Germany is the largest market for patient engagement solutions in Europe in 2022
    • TABLE 65 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 66 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 67 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 68 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 69 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • 12.3.2 FRANCE
      • 12.3.2.1 Digital health insurance startups in France to drive the market growth for patient engagement solutions
    • TABLE 70 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 71 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 72 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 73 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 74 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • 12.3.3 UK
      • 12.3.3.1 Favorable government initiatives to promote healthcare to support market growth in the UK
    • TABLE 75 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 76 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 77 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 78 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 79 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • 12.3.4 SPAIN
      • 12.3.4.1 Data security concerns restrict the market growth in Spain
    • TABLE 80 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 81 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 82 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 83 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 84 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • 12.3.5 ITALY
      • 12.3.5.1 The growing burden of chronic diseases in Italy drives the demand for patient engagement solutions
    • TABLE 85 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 86 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 87 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 88 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 89 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • 12.3.6 REST OF EUROPE (ROE)
    • TABLE 90 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 91 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 92 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 93 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 94 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
  • 12.4 ASIA PACIFIC
    • FIGURE 21 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
    • TABLE 95 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 96 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 97 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020-2027(USD MILLION)
    • TABLE 98 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 99 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 100 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 101 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2020-2027 (USD MILLION)
    • 12.4.1 JAPAN
      • 12.4.1.1 The rising geriatric population in Japan supports the market growth for patient engagement solutions
    • TABLE 102 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 103 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 104 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 105 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 106 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • 12.4.2 CHINA
      • 12.4.2.1 Implementation of EMR solutions in healthcare by the Chinese government is expected to drive the demand for patient engagement solutions
    • TABLE 107 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 108 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 109 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 110 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020-2027 USD MILLION)
    • TABLE 111 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020-2027(USD MILLION)
    • 12.4.3 INDIA
      • 12.4.3.1 High burden of chronic diseases to support the market growth for patient engagement solutions
    • TABLE 112 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 113 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 114 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 115 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 116 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • 12.4.4 REST OF ASIA PACIFIC (ROAPAC)
    • TABLE 117 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 118 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020-2027(USD MILLION)
    • TABLE 119 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 120 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020-2027(USD MILLION)
    • TABLE 121 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020-2027(USD MILLION)
  • 12.5 REST OF THE WORLD
    • TABLE 122 REST OF THE WORLD: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 123 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 124 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020-2027(USD MILLION)
    • TABLE 125 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 126 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 127 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • TABLE 128 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2020-2027 (USD MILLION)
    • 12.5.1 LATIN AMERICA
      • 12.5.1.1 Developments in healthcare infrastructure to support the market growth
    • TABLE 129 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 130 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 131 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 132 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 133 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)
    • 12.5.2 MIDDLE EAST & AFRICA
      • 12.5.2.1 Rising government support to drive the market growth for patient engagement solutions in the MEA
    • TABLE 134 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 135 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 136 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020-2027(USD MILLION)
    • TABLE 137 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 138 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020-2027 (USD MILLION)

13 COMPETITIVE LANDSCAPE

  • 13.1 OVERVIEW
  • 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE PATIENT ENGAGEMENT SOLUTIONS MARKET
  • 13.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
    • FIGURE 22 REVENUE ANALYSIS OF KEY PLAYERS IN THE PATIENT ENGAGEMENT SOLUTIONS MARKET
  • 13.4 MARKET RANKING
    • FIGURE 23 PATIENT ENGAGEMENT SOLUTIONS MARKET RANKING, BY KEY PLAYER, 2021
  • 13.5 COMPETITIVE BENCHMARKING
    • TABLE 139 PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
    • TABLE 140 PATIENT ENGAGEMENT SOLUTIONS MARKET: DETAILED LIST OF KEY STARTUP/SMES
  • 13.6 COMPETITIVE LEADERSHIP MAPPING
    • 13.6.1 STARS
    • 13.6.2 EMERGING LEADERS
    • 13.6.3 PERVASIVE PLAYERS
    • 13.6.4 PARTICIPANTS
    • FIGURE 24 PATIENT ENGAGEMENT SOLUTIONS MARKET (GLOBAL) COMPANY EVALUATION MATRIX, 2021
  • 13.7 COMPETITIVE LEADERSHIP MAPPING - START-UP/SME
    • 13.7.1 PROGRESSIVE COMPANIES
    • 13.7.2 STARTING BLOCKS
    • 13.7.3 RESPONSIVE COMPANIES
    • 13.7.4 DYNAMIC COMPANIES
    • FIGURE 25 COMPETITIVE LEADERSHIP MAPPING, START-UP/SME MATRIX MARKET
  • 13.8 COMPETITIVE SITUATIONS AND TRENDS
    • 13.8.1 PRODUCT LAUNCHES
    • 13.8.2 DEALS

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 14.1.1 IBM
    • TABLE 141 IBM: BUSINESS OVERVIEW
    • FIGURE 26 IBM: COMPANY SNAPSHOT (2021)
    • 14.1.2 MCKESSON CORPORATION
    • TABLE 142 MCKESSON CORPORATION: BUSINESS OVERVIEW
    • FIGURE 27 MCKESSON CORPORATION: COMPANY SNAPSHOT (2021)
    • 14.1.3 ALLSCRIPTS HEALTHCARE SOLUTIONS INC
    • TABLE 143 ALLSCRIPTS HEALTHCARE SOLUTIONS INC: BUSINESS OVERVIEW
    • FIGURE 28 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021)
    • 14.1.4 ATHENAHEALTH
    • TABLE 144 ATHENAHEALTH: BUSINESS OVERVIEW
    • 14.1.5 ORION HEALTH
    • TABLE 145 ORION HEALTH: BUSINESS OVERVIEW
    • 14.1.6 CERNER CORPORATION
    • TABLE 146 CERNER: BUSINESS OVERVIEW
    • FIGURE 29 CERNER CORPORATION: COMPANY SNAPSHOT (2021)
    • 14.1.7 GETWELLNETWORK, INC.
    • TABLE 147 GETWELL NETWORK INC: BUSINESS OVERVIEW
    • 14.1.8 LINCOR SOLUTIONS
    • TABLE 148 LINCOR SOLUTIONS: BUSINESS OVERVIEW
    • 14.1.9 COGNIZANT
    • TABLE 149 COGNIZANT: BUSINESS OVERVIEW
    • FIGURE 30 COGNIZANT: COMPANY SNAPSHOT (2020)
    • 14.1.10 HARRIS HEALTHCARE
    • TABLE 150 HARRIS HEALTHCARE: BUSINESS OVERVIEW
  • 14.2 OTHER KEY PLAYERS
    • 14.2.1 GET REAL HEALTH
    • 14.2.2 ONEVIEW HEALTHCARE
    • 14.2.3 ADVANCEDMD
    • 14.2.4 EPIC SYSTEMS CORPORATION
    • 14.2.5 MEDITECH
    • 14.2.6 KAREO
    • 14.2.7 ECLINICAL WORKS
    • 14.2.8 WELLSTACK
    • 14.2.9 IQVIA
    • 14.2.10 VIVIFY HEALTH
    • 14.2.11 MEDHOST
    • 14.2.12 VALIDIC
    • 14.2.13 CUREMD HEALTHCARE
    • 14.2.14 MEDISYSINC.COM
    • 14.2.15 PATIENTPOINT, LLC
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 AVAILABLE CUSTOMIZATIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS